@MondayNightIBD OnDemand: Addressing the Cases That Challenge Your Practice
Premiere Date: Monday, June 8, 2020This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- ABIM (MOC)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, June 8, 2021
Note: Credit Is No Longer Available
 | Aline Charabaty, MD, AGAF Clinical Director of Gastroenterology Director of Inflammatory Bowel Disease Center Sibley Memorial Hospital Assistant Professor of Medicine Johns Hopkins School of Medicine Washington, DC |
 | Uma Mahadevan, MD, AGAF, FACG Professor of Clinical Medicine Co-Director UCSF Center for Colitis and Crohn's Disease Director of Advanced IBD Fellowship Chief, GI Faculty Practice University of California, San Francisco San Francisco, CA |
 | Miguel Regueiro, MD, AGAF, FACG, FACP Chair, Digestive Disease and Surgery Chair, Department of Gastroenterology, Hepatology, and Nutrition The Pier C. and Renee A. Borra Family Endowed Chair in Gastroenterology and Hepatology Professor, Department of Medicine Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland, OH |
Gastroenterologists are trailblazers in health care social media, and @MondayNightIBD has harnessed that energy to establish gastroenterologists as not just social media influencers but as clinical practice influencers as well. @MondayNightIBD is not just a weekly social media conversation – it is an international platform that is moving the field forward by crowdsourcing the expertise of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients to meet the many challenges of IBD.
CME Outfitters partnered with @MondayNightIBD to bring its founder Dr. Aline Charabaty’s hugely successful endeavor to learners with this virtual symposium. True to the social media format, a panel of experts will discuss a series of patient cases and integrate onsite and Twitter polling with the goal of helping clinicians better understand, share, and implement optimal management strategies for IBD.
At the end of this CE activity, participants should be able to:
- Apply efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.
- Identify appropriate treatment strategies for special populations with IBD such as pregnant/lactating women, the elderly, and patients with Clostridioides difficile infection (CDI).
- Develop strategies, such as disease monitoring, therapeutic drug monitoring (TDM), shared decision-making (SDM), and patient education, to achieve optimal patient outcomes.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Explain efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.
- Identify appropriate treatment strategies for special populations with IBD such as pregnant/lactating women, the elderly, and patients with CDI.
- Describe strategies, such as disease monitoring, therapeutic drug monitoring (TDM), shared decision-making (SDM), and patient education, to achieve optimal patient outcomes.
Supported by educational grants from AbbVie Inc., Takeda Pharmaceuticals U.S.A., Inc., and UCB, Inc.
Gastroenterologists, primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs). Universal Activity Number:
Enduring: 0376-0000-20-081-H01-P
Type: knowledge-based
ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Format:
Live activity
Royal College MOC Credit:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
Note to PAs: PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately. This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Charabaty reports that she serves on the advisory committee for Janssen Pharmaceuticals, Inc. She is a consultant for AbbVie Inc.; Janssen Pharmaceuticals, Inc; and Pfizer Inc.
Dr. Mahadevan reports that she receives grants from Celgene Corporation; Genentech, Inc.; and Pfizer Inc. She is a consultant for AbbVie Inc.; Bristol Myers Squibb Company; Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Dr. Regueiro reports that he receives research support from AbbVie Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc. He receives unrestricted educational grants from AbbVie Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Salix Pharmaceuticals; Shire; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc.; He is on advisory boards and a consultant for AbbVie Inc.; Allergan; Amgen Inc; Celgene Corporation; Genentech, Inc.; Janssen Pharmaceuticals, Inc.; Miraca Laboratories; Pfizer Inc.; Salix Pharmaceuticals; Seres Therapeutics; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Olga Askinazi, PhD (planning committee) has no disclosures to report.
Susan Perry (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty has been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
MMV-100-060820-90
